Association of Renin-Angiotensin Inhibitor Treatment With Mortality and Heart Failure Readmission in Patients With Transcatheter Aortic Valve Replacement

IMPORTANCE: Data are lacking on the effect of a renin-angiotensin system (RAS) inhibitor prescribed after transcatheter aortic valve replacement (TAVR). Treatment with a RAS inhibitor may reverse left ventricular remodeling and improve function. OBJECTIVE: To investigate the association of prescript...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA
Main Authors: Inohara, Taku, Manandhar, Pratik, Kosinski, Andrzej S., Matsouaka, Roland A., Kohsaka, Shun, Mentz, Robert J., Thourani, Vinod H., Carroll, John D., Kirtane, Ajay J., Bavaria, Joseph E., Cohen, David J., Kiefer, Todd L., Gaca, Jeffrey G., Kapadia, Samir R., Peterson, Eric D., Vemulapalli, Sreekanth
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2018
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6583475/
https://ncbi.nlm.nih.gov/pubmed/30512100
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2018.18077
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados